Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New splicing mutations in propionic acidemia.

Lourdes R Desviat1, Sonia Clavero1, Celia Perez-Cerdá1

  • 1Centro de Biología Molecular "Severo Ochoa" CSIC-UAM, Universidad Autónoma de Madrid, Cantoblanco, 28049, Madrid, Spain.

Journal of Human Genetics
|October 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Outcomes of Patients with Distal Urea Cycle Disorders Detected by Newborn Screening: Data from the Spanish National Registry.

International journal of neonatal screening·2026
Same author

First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.

Journal of inherited metabolic disease·2026
Same author

Perivascular adipose tissue modulates aortic reactivity in Marfan syndrome mice in a sex- and region-specific manner: Redox-dependent anticontractile effects in the female ascending aorta.

Biochemical pharmacology·2026
Same author

Synthesis and Biological Profiling of New 1,2,3,4-Tetrahydrobenzo[<i>h</i>]naphthyridine-Based Hybrids as Dual Inhibitors of β-Amyloid and Tau Aggregation with Anticholinesterase Activity.

Biomolecules·2026
Same author

Structure-based virtual screening, in vitro and in silico analysis identified novel potent m6A demethylase FTO inhibitors as promising neurotherapeutic agents.

European journal of medicinal chemistry·2026
Same author

A brain-penetrant P2X7R antagonist mitigates Alzheimer's disease pathology.

bioRxiv : the preprint server for biology·2026
Same journal

Age-dependent association of the METTL23 c.84+60delAT variant with normal-tension glaucoma.

Journal of human genetics·2026
Same journal

Haplotype analysis of spinocerebellar ataxia type 36 suggests a shared permissive core haplotype across populations.

Journal of human genetics·2026
Same journal

Activation of cryptic donor splice site due to an exonic MYPN variant in congenital myopathy.

Journal of human genetics·2026
Same journal

The importance of integrating genetic testing into reproductive medicine: a retrospective observational study investigating the monogenic causes of human infertility in couples considering ICSI.

Journal of human genetics·2026
Same journal

Functional effect predictions for ion channel missense variants using a protein language model.

Journal of human genetics·2026
Same journal

A trio-based long-read sequencing workflow identifies a pathogenic transposable element insertion in a previously undiagnosed patient.

Journal of human genetics·2026
See all related articles

Seven novel splicing mutations in the PCCA and PCCB genes cause propionic acidemia (PA). These mutations, identified in Central Asian patients, disrupt propionyl-CoA carboxylase (PCC) enzyme function, emphasizing transcript analysis for accurate diagnosis.

Area of Science:

  • Genetics
  • Biochemistry
  • Molecular Biology

Background:

  • Propionic acidemia (PA) is a genetic disorder caused by mutations in the PCCA or PCCB genes, which encode subunits of the propionyl-CoA carboxylase (PCC) enzyme.
  • Splicing mutations can lead to altered protein function and disease phenotypes, but their specific impact in PA requires detailed investigation.

Purpose of the Study:

  • To identify and analyze novel splicing mutations in the PCCA and PCCB genes associated with propionic acidemia.
  • To investigate the functional consequences of these splicing mutations on PCC enzyme activity and transcript levels.
  • To explore the genetic epidemiology of splicing mutations in propionic acidemia, particularly in Central Asian populations.

Main Methods:

  • Identification of novel splicing mutations through genomic DNA sequencing.

Related Experiment Videos

  • Functional analysis of mutations using patient-derived fibroblasts.
  • Transcript quantification via real-time PCR to assess normally spliced transcript levels.

    • Main Results:

    • Seven novel splicing mutations were identified, affecting consensus donor and acceptor splice sites in PCCA and PCCB genes.
    • Mutations in PCCA (four identified) led to exon skipping and undetectable normally spliced transcripts.
    • Mutations in PCCB (three identified) also caused exon skipping, with one activating a cryptic splice site.

    Conclusions:

    • Splicing mutations are a significant cause of propionic acidemia, particularly in Central Asian populations, potentially due to founder effects.
    • Transcript analysis is crucial for fully characterizing the impact of splicing mutations, complementing genomic DNA sequencing.
    • These findings contribute to understanding the genetic basis and epidemiology of propionic acidemia.